Literature DB >> 12176521

A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.

R Shapiro1, V P Scantlebury, M L Jordan, C A Vivas, A Jain, T R Hakala, J McCauley, J Johnston, P Randhawa, S Fedorek, E Gray, A Chesky, I Dvorchik, J Donaldson, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176521      PMCID: PMC2948865          DOI: 10.1016/s0041-1345(02)02966-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.

Authors:  A Salazar; V C McAlister; B A Kiberd; H Bitter-Suermann; M F Al-Kerithy; A S MacDonald
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; J W Marsh; J McCauley; J Johnston; P Randhawa; W Irish; H A Gritsch; R Naraghi; T R Hakala; J J Fung; T E Starzl
Journal:  Transplantation       Date:  1999-02-15       Impact factor: 4.939

3.  Sirolimus-tacrolimus combination immunosuppression.

Authors:  V C McAlister; Z Gao; K Peltekian; J Domingues; K Mahalati; A S MacDonald
Journal:  Lancet       Date:  2000-01-29       Impact factor: 79.321

4.  Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.

Authors:  B D Kahan
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

  4 in total
  2 in total

Review 1.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Benefit-risk assessment of sirolimus in renal transplantation.

Authors:  Dirk R J Kuypers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.